Literature DB >> 15220374

An optimised protocol for the extraction of non-viral mRNA from human plasma frozen for three years.

S C C Wong1, E S F Lo, M T Cheung.   

Abstract

AIMS: To detect non-viral mRNA in human plasma that has been frozen for three years using a new protocol.
METHODS: Plasma from 15 patients with colorectal cancer and 10 normal subjects was separated and frozen with Trizol at -80 degrees C for three years. As a control measure, plasma from 10 of the 15 patients was separated using the same protocol but no Trizol during storage. After three years, all samples were extracted using Trizol and RNeasy before the reverse transcriptase polymerase chain reaction was performed to detect non-viral beta catenin mRNA. In addition, extraction of three plasma samples by Trizol or RNeasy independently was carried out for comparison.
RESULTS: beta Catenin mRNA was detected in all 15 patient plasma samples and only one of the 10 normal subjects. In contrast, no beta catenin mRNA was found in the control and patient samples that were independently extracted by Trizol and RNeasy kit.
CONCLUSIONS: This new protocol is a reliable method for extracting non-viral mRNA from the plasma of patients with cancer after longterm storage for three years. Extractions using Trizol and RNeasy kits independently could not isolate mRNA with sufficient quantity and quality for detection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220374      PMCID: PMC1770353          DOI: 10.1136/jcp.2003.007880

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Progress in the knowledge of circulating nucleic acids: plasma RNA is particle-associated. Can it become a general detection marker for a cancer blood test?

Authors:  Philippe Anker; Maurice Stroun
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

2.  Detection of APC mutations in fecal DNA from patients with colorectal tumors.

Authors:  Giovanni Traverso; Anthony Shuber; Bernard Levin; Constance Johnson; Louise Olsson; David J Schoetz; Stanley R Hamilton; Kevin Boynton; Kenneth W Kinzler; Bert Vogelstein
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

3.  Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells.

Authors:  J M Silva; R Rodriguez; J M Garcia; C Muñoz; J Silva; G Dominguez; M Provencio; P España; F Bonilla
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics.

Authors:  J M Silva; G Dominguez; J Silva; J M Garcia; A Sanchez; O Rodriguez; M Provencio; P España; F Bonilla
Journal:  Clin Cancer Res       Date:  2001-09       Impact factor: 12.531

5.  Detection of tumor messenger RNA in the serum of patients with malignant melanoma.

Authors:  M S Kopreski; F A Benko; L W Kwak; C D Gocke
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

6.  The DNA provirus hypothesis.

Authors:  H M Temin
Journal:  Science       Date:  1976-06-11       Impact factor: 47.728

Review 7.  Plasma nucleic acids in the diagnosis and management of malignant disease.

Authors:  Philip J Johnson; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

8.  Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

Authors:  Enders K O Ng; Nancy B Y Tsui; Nicole Y L Lam; Rossa W K Chiu; Simon C H Yu; S C Cesar Wong; Elena S F Lo; Timothy H Rainer; Philip J Johnson; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

9.  A simplified method for quantitation of human immunodeficiency virus type 1 (HIV1) RNA in plasma: clinical correlates.

Authors:  R B Stricker; Y S Zhu; B F Elswood
Journal:  Res Virol       Date:  1995 Mar-Apr

10.  Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong.

Authors:  S C C Wong; E S F Lo; A K C Chan; K C Lee; W L Hsiao
Journal:  Mol Pathol       Date:  2003-12
View more
  6 in total

1.  IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.

Authors:  Joy Jones Buie; Ludivine L Renaud; Robin Muise-Helmericks; Jim C Oates
Journal:  J Immunol       Date:  2017-08-04       Impact factor: 5.422

2.  Decoupling epigenetic and genetic effects through systematic analysis of gene position.

Authors:  Menzies Chen; Katherine Licon; Rei Otsuka; Lorraine Pillus; Trey Ideker
Journal:  Cell Rep       Date:  2013-01-03       Impact factor: 9.423

3.  Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.

Authors:  Giuseppe Pelosi; Elisabetta Schianchi; Patrizia Dell'orto; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Gabriella Sozzi; Elisabeth Brambilla; Claudia Griso; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-29       Impact factor: 4.064

4.  Evaluation of viremia, proviral load and cytokine profile in naturally feline immunodeficiency virus infected cats treated with two different protocols of recombinant feline interferon omega.

Authors:  Rodolfo O Leal; Solange Gil; Ana Duarte; David McGahie; Nuno Sepúlveda; Maria M R E Niza; Luís Tavares
Journal:  Res Vet Sci       Date:  2015-02-17       Impact factor: 2.534

5.  Expressions of IGFBP-5, cFLIP in cervical intraepithelial neoplasia, cervical carcinoma and their clinical significances: a molecular pathology.

Authors:  Xue-Jing Hou; You-Zhong Zhang; Xin Liu; Li-Hua Meng; Yun-Bo Qiao
Journal:  J Exp Clin Cancer Res       Date:  2009-05-28

6.  The Effect of Centrifugal Force in Quantification of Colorectal Cancer-Related mRNA in Plasma Using Targeted Sequencing.

Authors:  Vivian Weiwen Xue; Simon Siu Man Ng; Wing Wa Leung; Brigette Buig Yue Ma; William Chi Shing Cho; Thomas Chi Chuen Au; Allen Chi Shing Yu; Hin Fung Andy Tsang; Sze Chuen Cesar Wong
Journal:  Front Genet       Date:  2018-05-15       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.